Krysa
Use of 500
µg protein, peptide or protein sequence as starting material
Efficient immunization method, development of hybridoma cells, ELISA screening and subcloning
Antibodies against membrane proteins or other problematic proteins via proprietary immunization and screening technology
First
hybridoma supernatant 6 weeks after immunization start
Large-scale
production of up to 1 kg antibody
Additional
services or special activity tests upon request
Each step from immunization to antibody production
and purification can be ordered and quoted separately.
Cena na požádání
V této kategorii nejsou žádné výrobky.